Results 121 to 130 of about 18,955 (175)

Aumolertinib Versus Osimertinib as First‐Line Treatment for EGFR‐Mutant Non‐Small Cell Lung Cancer: A Retrospective Real‐World Multicenter Study

open access: yesInternational Journal of Cancer, Volume 159, Issue 10, Page 2575-2584, 15 November 2026.
As third‐generation EGFR‐tyrosine kinase inhibitors, both aumolertinib and osimertinib demonstrate clinical efficacy for non‐small cell lung adenocarcinoma, especially in patients with brain metastases. Currently, head‐to‐head studies comparing these two agents in real‐world settings are scarce.
Jinxia Wang   +9 more
wiley   +1 more source

Natural Course and Prognosis of Primary Spinal Glioblastoma: A Nationwide Study. [PDF]

open access: yesNeurology, 2023
Amelot A   +30 more
europepmc   +1 more source

Organoids in pediatric cancer research

open access: yesFEBS Letters, Volume 600, Issue 21, Page 3221-3240, November 2026.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source

Technical development and implementation of 3D‐QALAS on a 1.5T MR‐Linac for the brain: A prospective R‐IDEAL stage 0/1 technology development report

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 11, November 2026.
Abstract Background Quantitative relaxometry of the brain on the integrated MRI / linear accelerator (MR‐Linac) at high isotropic reconstructed resolution is currently limited due to prohibitively long scan times and limited field‐of‐views. Purpose The purpose of this study was to assess the technical feasibility of the 3D‐QALAS technique on the 1.5T ...
Lucas McCullum   +8 more
wiley   +1 more source

Évaluation de l’efficacité de la radiothérapie stéréotaxique pour le traitement des métastases cérébrales et extra-cérébrales de mélanome : étude rétrospective

open access: yes
CONTEXTE : la radiothérapie stéréotaxique est de plus en plus utilisée pour le traitement des mélanomes métastatiques, en combinaison avec d’autres thérapies systémiques. Cependant, son efficacité demeure variable d’un patient à un autre.
Jacquet, Clara
core   +1 more source

Brain metastases in a patient with antecedent of cardiac myxoma: a case report and review of literature [PDF]

open access: yesRev Fac Cien Med Univ Nac Cordoba
Solís-Gómez R   +6 more
europepmc   +1 more source

Advanced Materials for Biologics Delivery to Brain Tumors

open access: yesAdvanced Materials, Volume 38, Issue 61, 2 November 2026.
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng   +4 more
wiley   +1 more source

Prognostic factors for stage III/IV bronchopulmonary cancers in the North-West region of Tunisia. [PDF]

open access: yesTunis Med
Mahjoub N   +7 more
europepmc   +1 more source

L'oedème des métastases cérébrales, sa formation, sa mesure et son impact pronostique dans le cadre d’une irradiation en conditions stéréotaxiques

open access: yes
Médecine. Oncologie option RadiothérapieAprès avoir appréhendé les interactions que peuvent avoir les métastases cérébrales avec les cellules de l’immunité, nous avons émis l’hypothèse que l’œdème visible en IRM en séquence FLAIR serait un reflet ...
Pin Yvan
core  

Home - About - Disclaimer - Privacy